Biguanide

DB13100ApprovedInvestigationalWithdrawnSmall molecule

Biguanide has been investigated for the treatment of Diabetes Mellitus.

Chemical structure of Biguanide
Formula / weight
C2H7N5 · 101.113 g/mol (avg)

Resolves to

Compound
UNIIFB4Q52I9K2CAS56-03-1ChEBI3095PubChem5939KEGGC07672
Clinical / RWD
RxNorm1918319
Structure
InChIKeyXNCOSPRUTUOJCJ-UHFFFAOYSA-NSMILESNC(=N)NC(N)=N

What you can answer from here — as of March 31, 2026

13Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3Marketed productsAcross 1 country and 1 labeller
Sign in

Which companies are running trials of Biguanide, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In